OP

OncoLinea Pharmaceuticals

Employees
1–10
Business Model
B2B

About

OncoLinea Pharmaceuticals is a biopharmaceutical company created by Canaan Partners focused on novel mechanisms to treat cancer, including DNA repair inhibitors targeting the LINE-1 retrotransposon pathway. Co-founded by cancer genomics researchers, the company has operated in stealth mode with no public product details disclosed, and several academic conflict-of-interest disclosures link it to 'Oncolinea/PrimeFour Therapeutics.'

Summary

OncoLinea Pharmaceuticals is a Biotech company based in Menlo Park, United States.

Similar Companies